Indegene

Indegene Liabilities

The The Liabilities of Indegene (INDGN.NS) as of Nov 20, 2026 is 14.82 B INR. In the previous year, The Liabilities was 7.10 B INR — a change of 108.59% (higher).

Liabilities

14.82 BINR

YoY

108.59%

Last updated:

In 2026, Indegene's total liabilities amounted to 14.82 B INR, a 108.59% difference from the 7.10 B INR total liabilities in the previous year.

The Indegene Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2020
6.16 B INR
Jan 1, 2021
2.63 B INR
Jan 1, 2022
5.90 B INR
Jan 1, 2023
11.40 B INR
Jan 1, 2024
11.17 B INR
Jan 1, 2025
7.10 B INR
Jan 1, 2026
14.82 B INR
The Indegene Liabilities history
YEARLiabilitiesYoY
14.82 BINR+108.59%
7.10 BINR-36.38%
11.17 BINR-2.07%
11.40 BINR+93.39%
5.90 BINR+124.21%
2.63 BINR-57.30%
6.16 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Indegene Stock analysis

What does Indegene do? Indegene Ltd generates revenue by providing digital-led commercialization services to life sciences companies, including biopharmaceutical, emerging biotech, and medical devices firms. The company assists these clients with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and the sales and marketing of their products. This comprehensive support structure allows Indegene to serve as a key partner in the end-to-end commercialization process for its diverse client base within the life sciences sector. The company monetizes its offerings through specialized solution segments such as Omnichannel Activation, which helps life sciences companies leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. Additionally, Enterprise Commercial Solutions primarily involves assisting life sciences companies with their digital marketing operations, further expanding the company's service portfolio and revenue streams. Revenue is also derived from Enterprise Medical Solutions, where Indegene establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. The company rounds out its business model by offering enterprise clinical solutions and consultancy services, ensuring a holistic service delivery model that addresses various operational needs of its customers in the life sciences industry. Indegene is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Indegene's Liabilities

Indegene's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Indegene's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Indegene's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Indegene's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Indegene’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Indegene stock

The Liabilities of Indegene is 14.82 B INR in 2026.

The Liabilities of Indegene changed from 7.10 B INR to 14.82 B INR, representing a 108.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Indegene since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Indegene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Indegene

All Key Metrics — Indegene